Since the early 2000s, the FDA required a “black box” warning on products that use estrogen, progesterone, or both to treat ...
The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...
Protesters opposing bills that would limit transgender kids’ access to puberty blockers and hormone therapies rally at the Texas Capitol on March 1. Credit: Lauren Witte/The Texas Tribune Nearly ...
On November 10, the Food and Drug Administration announced it will remove the black box warning applied to estrogen-containing products since 2002. As the head of the FDA declared, “After 23 years of ...
The conversation around hormone replacement therapy (HRT) continues evolving as researchers uncover evidence suggesting benefits that extend well beyond the treatment of hot flashes and night sweats.
For most women, menopause occurs naturally around the age of 49. In the lead up to menopause, the quality and quantity of ...
In this episode of the Lupus Foundation of America's The Expert Series podcast, we explore the intersection of menopause and lupus, highlighting the unique challenges faced by women with lupus during ...
“Transition-related care” is an umbrella term referring to a range of social practices, hormone therapies, mental health treatments and medical procedures that support a person’s gender identity.